|
Shatalova N.A., Mirzaev K.B., Abdullaev Sh.P., Sozaeva Zh.A., Bochkov P.O., Asoskova A.V., Denisenko N.P., Kochetkov A.I., Ebzeeva E.Yu., Chernyaeva M.S., Shastina V.R., Ostroumova O.D., Sychev D.A.
On the possible relationship between the presence of polymorphic variants of CYP3A4/5 cytochrome genes, their metabolic activity with rivaroxaban pharmacokinetics and the development of bleeding in patients with non-valvular atrial fibrillation and chronic kidney disease
|
№1 / 2024
|
|
M.V. Leonova
Clinically significant drug interactions with warfarin: bleeding risk
|
№13 / 2022
|
|
I.V. Maev (1), E.Yu. Struchkova (1, 2), V.S. Fomin (1), V.Yu. Struchkov (3), I.V. Barkhatova (2), I.E. Mogilnitskiy (2), D.N. Andreev (1)
MULTIDISCIPLINARY APPROACH TO THE TREATMENT OF GASTRODUODENAL ULCER BLEEDINGS
|
№15 / 2016
|
|
I.N. Zakharova (1), I.V. Berezhnaya (2), Yu.A. Dmitrieva (1, 2), E.B. Machneva (1)
ANEMIA AGAINST THE BACKGROUND OF PATHOLOGY OF THE GASTROINTESTINAL TRACT IN CHILDREN: DIFFERENTIAL DIAGNOSIS
|
№11 / 2014
|
|
I.V. Mayev, A.A. Samsonov, D.N. Andreev
GASTROINTESTINAL BLEEDING: CLINICAL MANIFESTATION, DIAGNOSIS AND TREATMENT
|
№2 / 2014
|
|
O.N. Minushkin, L.V. Maslovsky, A.G. Shuleshova, Z.N. Golikova
TREATMENT AND PREVENTION OF GASTROINTESTINAL BLEEDING IN PATIENTS RECEIVING ANTIPLATELET/ANTICOAGULANT THERAPY
|
№14 / 2013
|
Русский
